Constellation Alpha Capital Corp. (CNAC) financial statements (2020 and earlier)

Company profile

Business Address 11099 N. TORREY PINES ROAD
LA JOLLA, CA 92037
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
3/31/2019
3/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1500
Cash and cash equivalents1500
Receivables1  
Inventory, net of allowances, customer advances and progress billings0  
Inventory0  
Prepaid expense100
Other current assets0  
Other undisclosed current assets0  
Total current assets:1701
Noncurrent Assets
Property, plant and equipment1  
Assets held-in-trust 12146
Other noncurrent assets0  
Total noncurrent assets:112146
TOTAL ASSETS:1812147
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:320
Accounts payable2  
Accrued liabilities0  
Employee-related liabilities1  
Other undisclosed accounts payable and accrued liabilities 20
Deferred revenue1
Due to related parties 00
Other undisclosed current liabilities1  
Total current liabilities:620
Noncurrent Liabilities
Other undisclosed noncurrent liabilities 55
Total noncurrent liabilities: 55
Total liabilities:675
Temporary equity, carrying amount 1137
Stockholders' equity
Stockholders' equity attributable to parent1255
Common stock034
Additional paid in capital104  
Retained earnings (accumulated deficit)(91)21
Total stockholders' equity:1255
TOTAL LIABILITIES AND EQUITY:1812147

Income statement (P&L) ($ in millions)

12/31/2019
3/31/2019
3/31/2018
Revenues3 0
Financial services revenue0
Cost of revenue(3)  
Gross profit:0 0
Operating expenses(18)(2)(0)
Other undisclosed operating loss  (0)
Operating loss:(18)(2)(0)
Nonoperating income (expense)(2)31
Investment income, nonoperating 31
Other nonoperating expense(0)  
Interest and debt expense1  
Income (loss) before gain (loss) on sale of properties:(19)11
Other undisclosed net loss(1)  
Net income (loss):(20)11
Other undisclosed net income (loss) attributable to parent 0(0)
Net income (loss) available to common stockholders, basic:(20)11
Dilutive securities, effect on basic earnings per share (0)1
Other undisclosed net loss available to common stockholders, diluted  (2)
Net income (loss) available to common stockholders, diluted:(20)1(0)

Comprehensive Income ($ in millions)

12/31/2019
3/31/2019
3/31/2018
Net income (loss):(20)11
Comprehensive income (loss), net of tax, attributable to parent:(20)11

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: